Skip to content
Search

Latest Stories

Centred Solutions partners with Paydens Pharmacy Group to provide FLOWRx Repeat Dispensing Hub technology

Centred Solutions, an automation and supply chain solution provider, has partnered with Paydens Pharmacy Group to provide them with the latest pharmacy hub and spoke solution.

The partnership will transform the way Paydens Group, an independent family-owned company, dispenses its repeat prescriptions.


The new system will not only allow pharmacy staff to focus on delivering services and improving patient care but also help in reducing errors.

Currently, repeat prescriptions are picked, labelled and sorted for dispensing manually by staff across all the branches, but once the new hub technology is installed, staff will no longer be required to spend hours administering and dispensing repeat prescriptions.

Pharmacies will receive labelled, sorted and bagged patient prescriptions straight from the hub ready to be collected by the patient in the spoke pharmacy.

Established in 1969, the group operates 113 pharmacies across the South-East of England.

The project will begin next month with the first 5 – 10 branches introducing the new system prior to a full roll out to the group.

Commenting on the partnership, Alexander Pay, managing director of Paydens said: “Paydens is committed to improving healthcare by seeking new ways of working and adapting to the future.  As an independent group we are able to respond quickly and make the right decisions for our teams and patients and we welcome the way that community pharmacy is evolving to become more focused on delivering services.

“Investing in new technology is key to making this happen and we believe that by taking this step it will enable our highly skilled, professional staff to provide an even better service to our communities”.

Paul O’Hanlon, managing director of Centred Solutions said: “We are thrilled to be forging this partnership with Paydens. It will be a true demonstration of how innovative technology can positively impact safety, drive efficiency and enable pharmacy professionals to spend more time on what matters most – face to face patient care.

“We look forward to beginning this journey with Paydens and inspiring other pharmacies across the UK and beyond to consider the value of our technology and what it can bring to a pharmacy business, whether that be a large pharmacy chain or single independent pharmacy looking for ways to improve their dispensing efficiency to release time for service delivery.”

The FlowRx product range, developed by the Centred Solutions, comprises three integrated solutions - FlowRx Connect, FlowRx Hub and FlowRx InStore. The system can work with most PMRs, WMS, robotic storage and dispensing systems, wholesalers or a combination of supply sources.

“Reducing the time they (pharmacists) spend on administrative tasks will enable them to focus on their patients and provide the very best services they can,” said John McConville, Paydens director of Pharmacy.

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less